Sancuso

A patent-protected transdermal patch containing granisetron to prevent chemotherapy-induced nausea and vomiting. Sancuso received approval from the US Food & Drug Administration in September 2008 and was launched in November 2008. This product is also undergoing the EU approval process.

For Patient Information Leaflet applicable to US patients only, click here